ID   CO1A1_RAT               Reviewed;        1453 AA.
AC   P02454; A3KNA1; P02455; Q63079;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   22-SEP-2009, sequence version 5.
DT   24-JUL-2024, entry version 195.
DE   RecName: Full=Collagen alpha-1(I) chain;
DE   AltName: Full=Alpha-1 type I collagen;
DE   Flags: Precursor;
GN   Name=Col1a1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Bone, and Tooth;
RX   PubMed=10065941; DOI=10.1177/00220345990780010101;
RA   Brandsten C., Lundmark C., Christersson C., Hammarstroem L., Wurtz T.;
RT   "Expression of collagen alpha1(I) mRNA variants during tooth and bone
RT   formation in the rat.";
RL   J. Dent. Res. 78:11-19(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Brown Norway; TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 152-170, ALLYSINE AT LYS-160, AND PYROGLUTAMATE
RP   FORMATION AT GLN-152.
RX   PubMed=5777344; DOI=10.1021/bi00829a010;
RA   Bornstein P.;
RT   "Comparative sequence studies of rat skin and tendon collagen. II. The
RT   absence of a short sequence at the amino terminus of the skin alpha-1
RT   chain.";
RL   Biochemistry 8:63-71(1969).
RN   [5]
RP   PROTEIN SEQUENCE OF 156-170.
RX   PubMed=5337886; DOI=10.1021/bi00855a019;
RA   Kang A.H., Bornstein P., Piez K.A.;
RT   "The amino acid sequence of peptides from the cross-linking region of rat
RT   skin collagen.";
RL   Biochemistry 6:788-795(1967).
RN   [6]
RP   PROTEIN SEQUENCE OF 171-206, AND HYDROXYLATION AT PRO-179; PRO-182;
RP   PRO-185; PRO-194; PRO-197 AND PRO-200.
RX   PubMed=4290711; DOI=10.1016/s0021-9258(18)96002-3;
RA   Bornstein P.;
RT   "The incomplete hydroxylation of individual prolyl residues in collagen.";
RL   J. Biol. Chem. 242:2572-2574(1967).
RN   [7]
RP   PROTEIN SEQUENCE OF 207-253.
RX   PubMed=4327399; DOI=10.1021/bi00787a018;
RA   Butler W.T., Ponds S.L.;
RT   "Chemical studies on the cyanogen bromide peptides of rat skin collagen.
RT   Amino acid sequence of alpha 1-CB4.";
RL   Biochemistry 10:2076-2081(1971).
RN   [8]
RP   PROTEIN SEQUENCE OF 254-290, HYDROXYLATION AT LYS-254, AND GLYCOSYLATION AT
RP   LYS-254.
RX   PubMed=5411206; DOI=10.1021/bi00803a006;
RA   Butler W.T.;
RT   "Chemical studies on the cyanogen bromide peptides of rat skin collagen.
RT   The covalent structure of alpha 1-CB5, the major hexose-containing cyanogen
RT   bromide peptide of alpha 1.";
RL   Biochemistry 9:44-50(1970).
RN   [9]
RP   PROTEIN SEQUENCE OF 291-389.
RX   PubMed=4335087; DOI=10.1021/bi00800a019;
RA   Balian G., Click E.M., Bornstein P.;
RT   "Structure of rat skin collagen alpha 1-CB8. Amino acid sequence of the
RT   hydroxylamine-produced fragment HA1.";
RL   Biochemistry 10:4470-4478(1971).
RN   [10]
RP   PROTEIN SEQUENCE OF 390-569.
RX   PubMed=4342027; DOI=10.1021/bi00770a020;
RA   Balian G., Click E.M., Hermodson M.A., Bornstein P.;
RT   "Structure of rat skin collagen alpha 1-CBB. Amino acid sequence of the
RT   hydroxyl amine-produced fragment HA2.";
RL   Biochemistry 11:3798-3806(1972).
RN   [11]
RP   PROTEIN SEQUENCE OF 570-718.
RX   PubMed=4366532; DOI=10.1021/bi00711a025;
RA   Butler W.T., Underwood S.P., Finch J.E. Jr.;
RT   "Chemical studies on the cyanogen bromide peptides of rat skin collagen.
RT   Amino acid sequence of alpha 1-CB3.";
RL   Biochemistry 13:2946-2953(1974).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 680-718.
RX   PubMed=6395893; DOI=10.1021/bi00320a049;
RA   Genovese C., Rowe D., Kream B.;
RT   "Construction of DNA sequences complementary to rat alpha 1 and alpha 2
RT   collagen mRNA and their use in studying the regulation of type I collagen
RT   synthesis by 1,25-dihydroxyvitamin D.";
RL   Biochemistry 23:6210-6216(1984).
RN   [13]
RP   PROTEIN SEQUENCE OF 1103-1186.
RX   PubMed=4126850; DOI=10.1111/j.1432-1033.1973.tb02987.x;
RA   Stoltz M., Timpl R., Furthmayr H., Kuehn K.;
RT   "Structural and immunogenic properties of a major antigenic determinant in
RT   neutral salt-extracted rat-skin collagen.";
RL   Eur. J. Biochem. 37:287-294(1973).
RN   [14]
RP   PROTEIN SEQUENCE OF 1186-1206.
RX   PubMed=4636751; DOI=10.1016/0014-5793(72)80542-8;
RA   Stoltz M., Timpl R., Kuehn K.;
RT   "Non-helical regions in rat collagen alpha 1-chain.";
RL   FEBS Lett. 26:61-65(1972).
RN   [15]
RP   INTERACTION WITH MRC2.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=15817460; DOI=10.1074/jbc.m501155200;
RA   Thomas E.K., Nakamura M., Wienke D., Isacke C.M., Pozzi A., Liang P.;
RT   "Endo180 binds to the C-terminal region of type I collagen.";
RL   J. Biol. Chem. 280:22596-22605(2005).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND PHOSPHORYLATION.
RA   Xiong X., Ghosh R., Hiller E., Drepper F., Knapp B., Brunner H., Rupp S.;
RT   "A new procedure for rapid, high yield purification of Type I collagen for
RT   tissue engineering.";
RL   Process Biochem. 44:1200-1212(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-161; SER-260 AND SER-776, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (5.16 ANGSTROMS) OF 152-1207.
RX   PubMed=16751282; DOI=10.1073/pnas.0502718103;
RA   Orgel J.P.R.O., Irving T.C., Miller A., Wess T.J.;
RT   "Microfibrillar structure of type I collagen in situ.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:9001-9005(2006).
CC   -!- FUNCTION: Type I collagen is a member of group I collagen (fibrillar
CC       forming collagen).
CC   -!- SUBUNIT: Trimers of one alpha 2(I) and two alpha 1(I) chains. Interacts
CC       with MRC2 (PubMed:15817460). Interacts with TRAM2. Interacts with MFAP4
CC       in a Ca (2+)-dependent manner. {ECO:0000250|UniProtKB:P02452,
CC       ECO:0000250|UniProtKB:P02453, ECO:0000269|PubMed:15817460}.
CC   -!- INTERACTION:
CC       P02454; Q9UBG0: MRC2; Xeno; NbExp=2; IntAct=EBI-915744, EBI-1104992;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000255|PROSITE-ProRule:PRU00793}.
CC   -!- TISSUE SPECIFICITY: Forms the fibrils of tendon, ligaments and bones.
CC       In bones the fibrils are mineralized with calcium hydroxyapatite.
CC   -!- DOMAIN: The C-terminal propeptide, also known as COLFI domain, have
CC       crucial roles in tissue growth and repair by controlling both the
CC       intracellular assembly of procollagen molecules and the extracellular
CC       assembly of collagen fibrils. It binds a calcium ion which is essential
CC       for its function. {ECO:0000250}.
CC   -!- PTM: Contains mostly 4-hydroxyproline. Proline residues at the third
CC       position of the tripeptide repeating unit (G-X-Y) are hydroxylated in
CC       some or all of the chains. {ECO:0000269|PubMed:5411206}.
CC   -!- PTM: Contains 3-hydroxyproline at a few sites. This modification occurs
CC       on the first proline residue in the sequence motif Gly-Pro-Hyp, where
CC       Hyp is 4-hydroxyproline. {ECO:0000250|UniProtKB:P11087}.
CC   -!- PTM: Lysine residues at the third position of the tripeptide repeating
CC       unit (G-X-Y) are 5-hydroxylated in some or all of the chains.
CC       {ECO:0000250|UniProtKB:P02457}.
CC   -!- PTM: O-glycosylated on hydroxylated lysine residues. The O-linked
CC       glycan consists of a Glc-Gal disaccharide.
CC       {ECO:0000269|PubMed:5411206}.
CC   -!- SIMILARITY: Belongs to the fibrillar collagen family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00793}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z78279; CAB01633.1; -; mRNA.
DR   EMBL; CH473948; EDM05727.1; -; Genomic_DNA.
DR   EMBL; BC133728; AAI33729.1; -; mRNA.
DR   EMBL; M11432; AAA40832.1; ALT_SEQ; mRNA.
DR   PIR; A90559; CGRT1S.
DR   RefSeq; NP_445756.1; NM_053304.1.
DR   PDB; 3HQV; Fiber; 5.16 A; A/C=152-1207.
DR   PDB; 3HR2; Fiber; 5.16 A; A/C=152-1207.
DR   PDBsum; 3HQV; -.
DR   PDBsum; 3HR2; -.
DR   AlphaFoldDB; P02454; -.
DR   SMR; P02454; -.
DR   BioGRID; 248045; 4.
DR   ComplexPortal; CPX-3104; Collagen type I trimer.
DR   DIP; DIP-36887N; -.
DR   IntAct; P02454; 6.
DR   STRING; 10116.ENSRNOP00000005311; -.
DR   GlyCosmos; P02454; 4 sites, No reported glycans.
DR   GlyGen; P02454; 4 sites.
DR   iPTMnet; P02454; -.
DR   PhosphoSitePlus; P02454; -.
DR   jPOST; P02454; -.
DR   PaxDb; 10116-ENSRNOP00000005311; -.
DR   Ensembl; ENSRNOT00000005311.7; ENSRNOP00000005311.5; ENSRNOG00000003897.7.
DR   Ensembl; ENSRNOT00055055926; ENSRNOP00055046083; ENSRNOG00055032354.
DR   Ensembl; ENSRNOT00060034429; ENSRNOP00060028260; ENSRNOG00060019866.
DR   Ensembl; ENSRNOT00065033789; ENSRNOP00065027042; ENSRNOG00065020003.
DR   GeneID; 29393; -.
DR   KEGG; rno:29393; -.
DR   UCSC; RGD:61817; rat.
DR   AGR; RGD:61817; -.
DR   CTD; 1277; -.
DR   RGD; 61817; Col1a1.
DR   eggNOG; KOG3544; Eukaryota.
DR   GeneTree; ENSGT00940000156584; -.
DR   HOGENOM; CLU_001074_2_3_1; -.
DR   InParanoid; P02454; -.
DR   OMA; YYDRDVW; -.
DR   OrthoDB; 2970887at2759; -.
DR   PhylomeDB; P02454; -.
DR   TreeFam; TF344135; -.
DR   Reactome; R-RNO-114604; GPVI-mediated activation cascade.
DR   Reactome; R-RNO-1442490; Collagen degradation.
DR   Reactome; R-RNO-1474244; Extracellular matrix organization.
DR   Reactome; R-RNO-1650814; Collagen biosynthesis and modifying enzymes.
DR   Reactome; R-RNO-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-RNO-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-RNO-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-RNO-216083; Integrin cell surface interactions.
DR   Reactome; R-RNO-2243919; Crosslinking of collagen fibrils.
DR   Reactome; R-RNO-3000171; Non-integrin membrane-ECM interactions.
DR   Reactome; R-RNO-3000178; ECM proteoglycans.
DR   Reactome; R-RNO-430116; GP1b-IX-V activation signalling.
DR   Reactome; R-RNO-75892; Platelet Adhesion to exposed collagen.
DR   Reactome; R-RNO-76009; Platelet Aggregation (Plug Formation).
DR   Reactome; R-RNO-8874081; MET activates PTK2 signaling.
DR   Reactome; R-RNO-8948216; Collagen chain trimerization.
DR   EvolutionaryTrace; P02454; -.
DR   PRO; PR:P02454; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Proteomes; UP000234681; Chromosome 10.
DR   Bgee; ENSRNOG00000003897; Expressed in quadriceps femoris and 18 other cell types or tissues.
DR   GO; GO:0005581; C:collagen trimer; ISO:RGD.
DR   GO; GO:0005584; C:collagen type I trimer; ISO:RGD.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0031012; C:extracellular matrix; ISO:RGD.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0030141; C:secretory granule; IDA:RGD.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; ISO:RGD.
DR   GO; GO:0030020; F:extracellular matrix structural constituent conferring tensile strength; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0048407; F:platelet-derived growth factor binding; ISO:RGD.
DR   GO; GO:0002020; F:protease binding; ISO:RGD.
DR   GO; GO:0001568; P:blood vessel development; ISO:RGD.
DR   GO; GO:0060346; P:bone trabecula formation; ISO:RGD.
DR   GO; GO:0060351; P:cartilage development involved in endochondral bone morphogenesis; ISO:RGD.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; ISO:RGD.
DR   GO; GO:0071364; P:cellular response to epidermal growth factor stimulus; IEP:RGD.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEP:RGD.
DR   GO; GO:1902618; P:cellular response to fluoride; IEP:RGD.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEP:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IEP:RGD.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEP:UniProtKB.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:RGD.
DR   GO; GO:0071306; P:cellular response to vitamin E; IEP:RGD.
DR   GO; GO:0032964; P:collagen biosynthetic process; ISO:RGD.
DR   GO; GO:0030199; P:collagen fibril organization; ISO:RGD.
DR   GO; GO:0038063; P:collagen-activated tyrosine kinase receptor signaling pathway; IDA:MGI.
DR   GO; GO:0048706; P:embryonic skeletal system development; ISO:RGD.
DR   GO; GO:0001958; P:endochondral ossification; ISO:RGD.
DR   GO; GO:0030198; P:extracellular matrix organization; IBA:GO_Central.
DR   GO; GO:0060325; P:face morphogenesis; ISO:RGD.
DR   GO; GO:0001957; P:intramembranous ossification; ISO:RGD.
DR   GO; GO:0010812; P:negative regulation of cell-substrate adhesion; ISO:RGD.
DR   GO; GO:0001503; P:ossification; IEP:RGD.
DR   GO; GO:0001649; P:osteoblast differentiation; ISO:RGD.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:0034504; P:protein localization to nucleus; ISO:RGD.
DR   GO; GO:0015031; P:protein transport; ISO:RGD.
DR   GO; GO:0051591; P:response to cAMP; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:1902617; P:response to fluoride; IEP:RGD.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:0055093; P:response to hyperoxia; IEP:RGD.
DR   GO; GO:0032868; P:response to insulin; IEP:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0043434; P:response to peptide hormone; IEP:RGD.
DR   GO; GO:0048545; P:response to steroid hormone; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0007605; P:sensory perception of sound; ISO:RGD.
DR   GO; GO:0001501; P:skeletal system development; ISO:RGD.
DR   GO; GO:0048705; P:skeletal system morphogenesis; ISO:RGD.
DR   GO; GO:0043588; P:skin development; ISO:RGD.
DR   GO; GO:0043589; P:skin morphogenesis; ISO:RGD.
DR   GO; GO:0034505; P:tooth mineralization; ISO:RGD.
DR   GO; GO:0007601; P:visual perception; ISO:RGD.
DR   Gene3D; 2.60.120.1000; -; 1.
DR   Gene3D; 2.10.70.10; Complement Module, domain 1; 1.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR050149; Collagen_superfamily.
DR   InterPro; IPR000885; Fib_collagen_C.
DR   InterPro; IPR001007; VWF_dom.
DR   PANTHER; PTHR24023; COLLAGEN ALPHA; 1.
DR   PANTHER; PTHR24023:SF1108; ENDOSTATIN DOMAIN-CONTAINING PROTEIN; 1.
DR   Pfam; PF01410; COLFI; 1.
DR   Pfam; PF01391; Collagen; 9.
DR   Pfam; PF00093; VWC; 1.
DR   SMART; SM00038; COLFI; 1.
DR   SMART; SM00214; VWC; 1.
DR   SUPFAM; SSF57603; FnI-like domain; 1.
DR   PROSITE; PS51461; NC1_FIB; 1.
DR   PROSITE; PS01208; VWFC_1; 1.
DR   PROSITE; PS50184; VWFC_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Collagen; Direct protein sequencing; Disulfide bond;
KW   Extracellular matrix; Glycoprotein; Hydroxylation; Metal-binding;
KW   Phosphoprotein; Pyrrolidone carboxylic acid; Reference proteome; Repeat;
KW   Secreted; Signal.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   PROPEP          23..151
FT                   /note="N-terminal propeptide"
FT                   /evidence="ECO:0000269|PubMed:5777344"
FT                   /id="PRO_0000043358"
FT   CHAIN           152..1207
FT                   /note="Collagen alpha-1(I) chain"
FT                   /id="PRO_0000043359"
FT   PROPEP          1208..1453
FT                   /note="C-terminal propeptide"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000043360"
FT   DOMAIN          29..87
FT                   /note="VWFC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00220"
FT   DOMAIN          1218..1453
FT                   /note="Fibrillar collagen NC1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   REGION          97..1206
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          152..167
FT                   /note="Nonhelical region (N-terminal)"
FT   REGION          168..1181
FT                   /note="Triple-helical region"
FT   REGION          1176..1186
FT                   /note="Major antigenic determinant (of neutral salt-
FT                   extracted rat skin collagen)"
FT   REGION          1182..1207
FT                   /note="Nonhelical region (C-terminal)"
FT   MOTIF           734..736
FT                   /note="Cell attachment site"
FT                   /evidence="ECO:0000255"
FT   MOTIF           1082..1084
FT                   /note="Cell attachment site"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        108..144
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        172..215
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        538..554
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        831..845
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        877..891
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1165..1184
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         1266
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         1268
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         1269
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         1271
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         1274
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         152
FT                   /note="Pyrrolidone carboxylic acid"
FT                   /evidence="ECO:0000269|PubMed:5777344"
FT   MOD_RES         160
FT                   /note="Allysine"
FT                   /evidence="ECO:0000269|PubMed:5777344"
FT   MOD_RES         161
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         179
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000305|PubMed:4290711"
FT   MOD_RES         182
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000305|PubMed:4290711"
FT   MOD_RES         185
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000305|PubMed:4290711"
FT   MOD_RES         194
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000305|PubMed:4290711"
FT   MOD_RES         197
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000305|PubMed:4290711"
FT   MOD_RES         200
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000305|PubMed:4290711"
FT   MOD_RES         215
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         230
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         236
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         245
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         251
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         254
FT                   /note="5-hydroxylysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:5411206"
FT   MOD_RES         260
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         278
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         281
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         287
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         296
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         302
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         323
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         332
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         335
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         362
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         365
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         377
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         383
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         392
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         398
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         401
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         416
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         419
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         425
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         428
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         440
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         449
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         464
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         470
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         479
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         485
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         494
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         503
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         512
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         518
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         524
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         533
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         536
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         545
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         554
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         560
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         572
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         581
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         590
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         593
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         611
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         629
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         635
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         641
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         647
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         653
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         659
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         671
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         680
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         692
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         704
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         707
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         713
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         719
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         728
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         740
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         746
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         761
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         767
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         776
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         788
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         794
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         797
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         806
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         812
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         830
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         839
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         848
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         851
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         860
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         866
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         874
FT                   /note="3-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         875
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         884
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         887
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         908
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         917
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         926
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         935
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         953
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         962
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         965
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         971
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         986
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         992
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         998
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1007
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1013
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1022
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1034
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1037
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1040
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1085
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1097
FT                   /note="5-hydroxylysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1109
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1112
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1115
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1133
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   MOD_RES         1148
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1153
FT                   /note="3-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1154
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1168
FT                   /note="3-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1169
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1171
FT                   /note="3-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1172
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1174
FT                   /note="3-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1175
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1178
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1181
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:P11087"
FT   MOD_RES         1197
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P02453"
FT   CARBOHYD        56
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        254
FT                   /note="O-linked (Gal...) hydroxylysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:5411206"
FT   CARBOHYD        1097
FT                   /note="O-linked (Gal...) hydroxylysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P02457"
FT   CARBOHYD        1354
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        1248..1280
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   DISULFID        1254
FT                   /note="Interchain (with C-1271)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   DISULFID        1271
FT                   /note="Interchain (with C-1254)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   DISULFID        1288..1451
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   DISULFID        1359..1404
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   CONFLICT        143
FT                   /note="P -> L (in Ref. 1; CAB01633)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        202
FT                   /note="A -> G (in Ref. 1; CAB01633)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        209
FT                   /note="R -> P (in Ref. 1; CAB01633)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        232
FT                   /note="E -> Q (in Ref. 7; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        268
FT                   /note="D -> N (in Ref. 8; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        286
FT                   /note="A -> T (in Ref. 1; CAB01633)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        307
FT                   /note="S -> T (in Ref. 1; CAB01633)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        313
FT                   /note="N -> D (in Ref. 9; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        421
FT                   /note="N -> T (in Ref. 1; CAB01633)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        497
FT                   /note="A -> S (in Ref. 1; CAB01633)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        773
FT                   /note="T -> A (in Ref. 1; CAB01633)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        794
FT                   /note="P -> A (in Ref. 1; CAB01633)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        958
FT                   /note="E -> K (in Ref. 1; CAB01633)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1111
FT                   /note="S -> P (in Ref. 13; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1163
FT                   /note="S -> A (in Ref. 13; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1166
FT                   /note="A -> S (in Ref. 13; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1187
FT                   /note="F -> L (in Ref. 14; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1190
FT                   /note="L -> F (in Ref. 14; AA sequence)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1453 AA;  137953 MW;  BCDDC40C3167AE59 CRC64;
     MFSFVDLRLL LLLGATALLT HGQEDIPEVS CIHNGLRVPN GETWKPDVCL ICICHNGTAV
     CDGVLCKEDL DCPNPQKREG ECCPFCPEEY VSPDAEVIGV EGPKGDPGPQ GPRGPVGPPG
     QDGIPGQPGL PGPPGPPGPP GPPGLGGNFA SQMSYGYDEK SAGVSVPGPM GPSGPRGLPG
     PPGAPGPQGF QGPPGEPGEP GASGPMGPRG PPGPPGKNGD DGEAGKPGRP GERGPPGPQG
     ARGLPGTAGL PGMKGHRGFS GLDGAKGDTG PAGPKGEPGS PGENGAPGQM GPRGLPGERG
     RPGPPGSAGA RGNDGAVGAA GPPGPTGPTG PPGFPGAAGA KGEAGPQGAR GSEGPQGVRG
     EPGPPGPAGA AGPAGNPGAD GQPGAKGANG APGIAGAPGF PGARGPSGPQ GPSGAPGPKG
     NSGEPGAPGN KGDTGAKGEP GPAGVQGPPG PAGEEGKRGA RGEPGPSGLP GPPGERGGPG
     SRGFPGADGV AGPKGPAGER GSPGPAGPKG SPGEAGRPGE AGLPGAKGLT GSPGSPGPDG
     KTGPPGPAGQ DGRPGPAGPP GARGQAGVMG FPGPKGTAGE PGKAGERGVP GPPGAVGPAG
     KDGEAGAQGA PGPAGPAGER GEQGPAGSPG FQGLPGPAGP PGEAGKPGEQ GVPGDLGAPG
     PSGARGERGF PGERGVQGPP GPAGPRGNNG APGNDGAKGD TGAPGAPGSQ GAPGLQGMPG
     ERGAAGLPGP KGDRGDAGPK GADGSPGKDG VRGLTGPIGP PGPAGAPGDK GETGPSGPAG
     PTGARGAPGD RGEPGPPGPA GFAGPPGADG QPGAKGEPGD TGVKGDAGPP GPAGPAGPPG
     PIGNVGAPGP KGSRGAAGPP GATGFPGAAG RVGPPGPSGN AGPPGPPGPV GKEGGKGPRG
     ETGPAGRPGE VGPPGPPGPA GEKGSPGADG PAGSPGTPGP QGIAGQRGVV GLPGQRGERG
     FPGLPGPSGE PGKQGPSGAS GERGPPGPMG PPGLAGPPGE SGREGSPGAE GSPGRDGAPG
     AKGDRGETGP AGPPGAPGAP GAPGPVGPAG KNGDRGETGP AGPAGPIGPA GARGPAGPQG
     PRGDKGETGE QGDRGIKGHR GFSGLQGPPG SPGSPGEQGP SGASGPAGPR GPPGSAGSPG
     KDGLNGLPGP IGPPGPRGRT GDSGPAGPPG PPGPPGPPGP PSGGYDFSFL PQPPQEKSQD
     GGRYYRADDA NVVRDRDLEV DTTLKSLSQQ IENIRSPEGS RKNPARTCRD LKMCHSDWKS
     GEYWIDPNQG CNLDAIKVYC NMETGQTCVF PTQPSVPQKN WYISPNPKEK KHVWFGESMT
     DGFQFEYGSE GSDPADVAIQ LTFLRLMSTE ASQNITYHCK NSVAYMDQQT GNLKKSLLLQ
     GSNEIELRGE GNSRFTYSTL VDGCTSHTGT WGKTVIEYKT TKTSRLPIID VAPLDIGAPD
     QEFGMDIGPA CFV
//
